NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
10-K/A - Moleculin Biotech, Inc.
Filed:
2026-04-14
AccNo:
0001437749-26-012273
Size:
640 KB
发布时间04/14 21:26 UTC
首次发现04/14 21:27 UTC
热度108.0
重要度90
情绪+0.03
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 705 字符
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] SEC Accession No. 0001437749-26-012273
Filing Date: 2026-04-14
Accepted: 2026-04-14 17:26:57
Documents: 14
Period of Report: 2025-12-31
Moleculin Biotech, Inc. (Filer) CIK : 0001659617 (see all company filings) EIN. : 474671997 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 10-K/A | Act: 34 | File No.: 001-37758 | Film No.: 26861801 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 10-K/A | mbrx20251231_10ka.htm iXBRL | 10-K/A
2 | EXHIBIT 31.3 | ex_932678.htm | EX-31.3
3 | EXHIBIT 31.4 | ex_932679.htm | EX-31.4
4 | XBRL TAXONOMY EXTENSION SCHEMA | mbrx-20251231.xsd | EX-101.SCH